Bradda Head Lithium Ltd Announces Unaudited Interim Financial Statements

Bradda Head Lithium Ltd Announces Unaudited Interim Financial Statements

 

Unaudited Condensed Consolidated Interim Financial Statements
For the nine-month period ended November 30, 2022

 

Notice of No Auditor Review

 

These unaudited condensed consolidated interim financial statements of Bradda Head Lithium Limited (the "Company") have not been reviewed by the auditors of the Company

 

Condensed Interim Consolidated Statement of Comprehensive Income

 Bradda Head Lithium Limited, Friday, January 27, 2023, Press release picture
 
 

for the period ended November 30, 2022

 
                                                                                                                                                                                                           
   

Nine-month period ended November 30, 2022

 

(unaudited)

 
 

Nine-month period ended November 30, 2021

 

(unaudited)

 
 

Three-month period ended November 30, 2022

 

(unaudited)

 
 

Three-month period ended November 30, 2021

 

(unaudited)

 
 
 

Notes

US$

US$

US$

US$

 
Expenses      
General and administrative

2

(4,242,520)

(2,391,522)

(1,690,543)

(764,201)

 
Share based payment and warrant expense

10

(1,285,743)

(259,816)

(91,539)

(119,726)

 
Foreign exchange loss 

(1,255,343)

(34,338)

(944,005)

(4,197)

 
  

────────

────────

────────

────────

 
Operating loss 

(6,783,606)

(2,685,676)

(2,726,087)

(888,124)

 
       
Other income      
Warrant fair value re-measurement

11

3,711,264

-

880,920

-

 
Unrealised (loss) / gain on investment 

(2,520)

13,360

-

5,461

 
  

────────

────────

────────

────────

 
Loss before finance costs 

(3,074,862)

(2,672,316)

(1,845,167)

(882,663)

 
       
Finance costs 

-

(32,832)

-

-

 
  

────────

────────

────────

────────

 
Loss before income tax 

(3,074,862)

(2,705,148)

(1,845,167)

(882,663)

 
       
Income tax expense 

-

-

-

-

 
  

────────

────────

────────

────────

 
Loss for the period 

(3,074,862)

(2,705,148)

(1,845,167)

(882,663)

 
  

══════

══════

══════

══════

 
Other comprehensive income - foreign currency translation reserve 

-

186

-

-

 
  

────────

────────

────────

────────

 
Total comprehensive loss for the period 

(3,074,862)

(2,704,962)

(1,845,167)

(882,663)

 
  

══════

══════

══════

══════

 
       
Basic and diluted loss per share (US cents)

12

(0.81)

(1.50)

(0.49)

(0.49)

 
 

The accompanying notes are an integral part of these consolidated interim financial statements.

 

Condensed Interim Consolidated Statement of Financial Position

 

as at November 30, 2022

 
                                                                                                                                                                                                      
 

Notes

   

November 30, 2022

 

(unaudited)

 
 

February 28, 2022

 

(audited)

 
    

US$

US$

Non-Current assets     
Deferred mining and exploration costs

3

  

5,911,902

4,183,744

Exploration permits and licences

4

  

2,255,368

1,549,076

Plant and equipment

8

  

89,134

54,170

Advances and deposits

6

  

507,906

88,594

Investment   

51,436

53,957

    

───────

───────

Total non-current assets   

8,815,746

5,929,541

    

───────

───────

Current assets     
Cash and cash equivalents   

10,603,037

7,327,303

Trade and other receivables

6

  

165,786

97,996

    

───────

───────

Total current assets   

10,768,823

7,425,299

    

───────

───────

Total assets   

19,584,569

13,354,840

    

═══════

═══════

Equity     
Share premium

9

  

30,467,820

23,434,385

Retained deficit   

(12,966,339)

(11,177,220)

    

───────

───────

Total equity   

17,501,481

12,257,165

    

───────

───────

Current liabilities     
Trade and other payables

7

  

1,071,603

1,097,675

Warrant liability

11

  

1,011,485

-

    

───────

───────

Total current liabilities   

2,083,088

1,097,675

    

───────

───────

Total equity and liabilities   

19,584,569

13,354,840

    

═══════

═══════

 

The accompanying notes are an integral part of these consolidated interim financial statements.

 

These condensed interim consolidated financial statements were approved by the Board of Directors on January 27, 2023 and were signed on their behalf by:

 

Denham Eke

 

Director

 

Condensed Interim Consolidated Statement of Changes in Equity

 

for the period ended November 30, 2022

 
                                                                                                    
     
  

Share premium

Retained deficit

Total

  

US$

US$

US$

     

Balance at March 1, 2022 (audited)

 

23,434,385

(11,177,220)

12,257,165

     

Total comprehensive loss for the period

    

Loss for the period

 

-

(3,074,862)

(3,074,862)

  

──────

───────

───────

Total comprehensive loss for the period

 

-

(3,074,862)

(3,074,862)

     

Transactions with owners of the Company

    

Issue of ordinary shares (note 9 and note 11)

 

7,581,351

-

7,581,351

Share issue costs capitalised (note 9)

 

(547,916)

-

(547,916)

Equity settled share-based payments (note 10)

 

-

1,285,743

1,285,743

  

──────

───────

──────

Total transactions with owners of the Company

 

7,033,435

1,285,743

8,319,178

  

──────

───────

──────

Balance at November 30, 2022 (unaudited)

 

30,467,820

(12,966,339)

17,501,481

  

═══════

═══════

═══════

 

The accompanying notes are an integral part of these consolidated interim financial statements.

 

Condensed Interim Consolidated Statement of Changes in Equity

 

for the period ended November 30, 2022 (continued)

 
                                                                                                                                               
      
  

Share premium

Retained deficit

Foreign currency translation reserve

Total

  

US$

US$

US$

US$

      

Balance at March 1, 2021 (audited)

 

9,443,676

(9,056,687)

186

387,175

      

Total comprehensive loss for the period

     

Loss for the period

 

-

(2,705,148)

-

(2,705,148)

  

──────

───────

───────

───────

Total comprehensive loss for the period

 

-

(2,705,148)

-

(2,705,148)

      

Transactions with owners of the Company

     

Issue of ordinary shares (note 8)

 

11,904,439

-

-

11,904,439

Share issue costs capitalised (note 8)

 

(413,731)

-

-

(413,731)

Equity settled share-based payments (note 9)

 

-

259,816

-

259,816

Transfer to retained deficit

 

-

186

(186)

-

  

──────

───────

───────

──────

Total transactions with owners of the Company

 

11,490,708

260,002

(186)

11,750,524

  

──────

───────

───────

──────

Balance at November 30, 2021 (unaudited)

 

20,934,384

(11,501,833)

-

9,432,551

  

═══════

═══════

═══════

═══════

      
           
 

The accompanying notes are an integral part of these consolidated interim financial statements.

 

Condensed Interim Consolidated Statement of Cash Flows

 

for the period ended November 30, 2022

 
                                                                                                                                                                                                                                                                                    
 

Notes

 

Nine-month period ended November 30, 2022

 

(unaudited)

 
 

Nine-month period ended November 30, 2021

 

(unaudited)

 
 

Three-month period ended November 30, 2022

 

(unaudited)

 
 

Three-month period ended November 30, 2021

 

(unaudited)

 
  

US$

US$

US$

US$

Cash flows from operating activities     
Loss before income tax 

(3,074,862)

(2,705,148)

(1,845,167)

(882,663)

      
Adjusted for non-cash and non-operating items:     
Depreciation

8

23,708

-

9,532

-

Unrealised loss/(gain) on investment 

2,520

(13,360)

-

(5,461)

Non-cash interest expense 

-

32,832

-

-

Equity settled share based payments expense

10, 11

1,285,743

259,816

91,539

119,726

Warrant fair value re-measurement

11

(3,711,264)

-

(880,920)

-

Unrealised FX adjustment on convertible loan note 

-

-

-

-

Unrealised FX on cash balances 

1,255,343

(34,338)

944,005

(4,197)

  

───────

───────

───────

───────

  

(4,218,812)

(2,460,198)

(1,681,011)

(772,595)

      
Change in trade and other receivables 

(487,103)

51,470

(26,609)

255,140

Change in trade and other payables 

(26,070)

341,132

717,835

226,133

  

───────

───────

───────

───────

Net cash flows used by operating activities 

(4,731,985)

(2,067,596)

(989,785)

(291,322)

      
Cash flows from investing activities     
Amounts paid for deferred mining and exploration costs

3

(1,728,158)

(1,121,721)

(1,452,815)

(964,459)

Amounts paid for licences and permits

4

(706,292)

(519,455)

(16,495)

(112,018)

Equipment purchased

8

(58,672)

-

-

-

  

───────

───────

───────

───────

Net cash flows used by investing activities 

(2,493,122)

(1,641,176)

(1,469,310)

(1,076,477)

      
Cash flows from financing activities     
Short-term loan received 

-

60,000

-

-

Cash received from shares and warrants issued

9, 11

12,304,100

9,598,923

-

-

Share issue costs paid

9

(547,916)

(413,731)

-

-

  

───────

───────

───────

───────

Net cash flows from financing activities 

11,756,184

9,245,192

-

-

  

───────

───────

───────

───────

Increase / (decrease) in cash and cash equivalents 

4,531,077

5,536,420

(2,459,095)

(1,367,799)

      
Cash and cash equivalents at beginning of period 

7,327,303

86,972

14,006,137

7,021,332

      

Effect of foreign exchange on cash balances

 

(1,255,343)

34,338

(944,005)

4,197

  

───────

───────

───────

───────

Cash and cash equivalents at end of period

 

10,603,037

5,657,730

10,603,037

5,657,730

  

═══════

═══════

═══════

═══════

      
      
      
 

The accompanying notes are an integral part of these consolidated interim financial statements.

 

1 Reporting Entity and basis of preparation

 

Bradda Head Lithium Limited (the "Company") is a company domiciled in the British Virgin Islands. The address of the Company's registered office is Craigmuir Chambers, Road Town, Tortola, British Virgin Islands. The Company and its subsidiaries together are referred to as the "Group".

 

The Company is a lithium exploration Group focused on developing its projects in the USA.

 

These interim financial statements have been prepared in accordance with IAS 34 Interim Financial Reporting and should be read in conjunction with the last annual consolidated financial statements as at and for the year ended February 28, 2022 ("last annual financial statements"). They do not include all of the information required for a complete set of IFRS financial statements. However, selected explanatory notes are included to explain events and transactions that are significant to an understanding of the changes in the Group's financial position and performance since the last annual financial statements.

 

The financial information in this report has been prepared in accordance with the Company's accounting policies and in consistency with the last annual financial statements. Full details of the accounting policies adopted by the Company are contained in the financial statements included in the Company's annual report for the year ended February 28, 2022, which is available on the Group's website: www.braddheadltd.com, and on SEDAR at www.sedar.com. These unaudited condensed consolidated interim financial statements should be read in conjunction with the audited Consolidated Financial Statements for the year ended February 28, 2022.

 

2 General and administrative

 

The Group's general and administrative expenses include the following:

 
                                                       
  

Nine-month period ended November 30, 2022

 

(unaudited)

 

US$

 
 

Nine-month period ended November 30, 2021

 

(unaudited)

 

US$

 
 

Three-month period ended November 30, 2022

 

(unaudited)

 

US$

 
 

Three-month period ended November 30, 2021

 

(unaudited)

 

US$

 
     

Auditors' fees

114,508

62,067

13,067

35,466

Directors and management fees and salaries

402,231

310,653

132,955

120,942

Legal and accounting

422,228

510,218

247,291

83,665

Contractor costs

1,979,619

732,407

719,097

280,162

Professional and marketing costs

942,495

535,899

332,928

203,672

Other administrative costs

381,439

240,278

245,205

40,294

 

───────

───────

───────

───────

Total

4,242,520

2,391,522

1,690,543

764,201

 

═══════

═══════

═══════

═══════

 

3 Deferred mine exploration costs

 

The schedule below details the exploration costs capitalised to date:

 
                                    
 

Total

 

US$

Cost and net book value

 

At February 28, 2021 (audited)

1,767,274

  

Capitalised during the year

2,501,853

Disposal under the royalty agreement

(85,383)

 

───────

At February 28, 2022 (audited)

4,183,744

 

───────

Capitalised during the period

1,728,158

 

───────

At November 30, 2022 (unaudited)

5,911,902

 

═══════

Cost and net book value

 

At November 30, 2022 (unaudited)

5,911,902

At February 28, 2022 (audited)

4,183,744

 

═══════

 

The recoverability of the carrying amounts of exploration and evaluation assets is dependent on the successful development and commercial exploitation or sale of the respective area of interest, as well as maintaining the assets in good standing. The Group assessed the DMEC relating to areas for which licenses and permits are held, for impairment as at November 30, 2022. The Board concluded that no facts and circumstances have been identified which suggest the recoverable amount of these assets would not exceed the carrying amount and, as such, no impairment was recognised during the period.

 

During the year ended February 28, 2022, an impairment charge of US$ Nil was recognised.

 

4 Exploration permits and licences

 

The schedule below details the exploration permit and licence costs capitalised to date:

 
                                      
 

Total

 

US$

Cost and net book value

 

At February 28, 2021 (audited)

691,465

  

Capitalised during the year

1,119,455

Disposal under the royalty agreement

(31,614)

Impairment

(230,230)

 

───────

At February 28, 2022 (audited)

1,549,076

  

Capitalised during the period

706,292

 

───────

At November 30, 2022 (unaudited)

2,255,368

 

═══════

Cost and net book value

 

At November 30, 2022 (unaudited)

2,255,368

At February 28, 2022 (audited)

1,549,076

 

═══════

 

The Group assessed the carrying amount of the licences and permits held for impairment as at November 30, 2022. The Board concluded that no facts and circumstances have been identified which suggest the recoverable amount of these assets would not exceed the carrying amount and, as such, no impairment was recognised during the period.

 

During the year ended February 28, 2022, an impairment charge of US$ 230,230 was recognised as a result of project licences and permits that were not renewed.

 

5 Investment in subsidiary undertakings

 

As at November 30, 2022 and February 28, 2022, the Group had the following subsidiaries:

 
                        

Name of company

Place of incorporationOwnership interestPrincipal activity

Bradda Head Limited*

BVI100%Holding company of entities below

Zenolith (USA) LLC

USA100%Holds USA lithium licences and permits

Verde Grande LLC

USA100%Holds USA lithium licences and permits

Gray Wash LLC

USA100%Holds USA lithium licences and permits
    
 

* Held directly by the Company. All other holdings are indirectly held through Bradda Head Limited

 

The condensed interim consolidated financial statements include the results of the subsidiaries for the full interim period from March 1, 2022 to November 30, 2022, and up to the date that control ceases.

 

6 Trade and other receivables and advances and deposits

 

Non-current

 
            
  

November 30, 2022

 

(unaudited)

 
 

February 28, 2022

 

(audited)

 
 

US$

US$

Advances and deposits

507,906

88,594

 

══════

══════

 

Current

 
            
  

November 30, 2022

 

(unaudited)

 
 

February 28, 2022

 

(audited)

 
 

US$

US$

Prepayments and other debtors

165,786

97,996

 

══════

══════

 

7 Trade and other payables

 
                     
  

November 30, 2022

 

(unaudited)

 
 

February 28, 2022

 

(audited)

 
 

US$

US$

Trade payables

950,402

1,019,175

Accrued expenses and other payables

121,201

78,500

 

──────

──────

 

1,071,603

1,097,675

 

══════

══════

 

8 Plant and equipment

 
                                    
   
 

Motor vehicle

Total

Cost

US$

US$

As at March 1, 2021 (audited)

-

-

Additions during the year

55,718

55,718

 

──────

──────

As at February 28, 2022 (audited)

55,718

55,718

   

Additions during the period

58,672

58,672

 

──────

──────

As at November 30, 2022 (unaudited)

114,390

114,390

 

══════

══════

 

8 Plant and equipment (continued)

 
                                             
 

Motor vehicle

Total

Accumulated depreciation

US$

US$

As at March 1, 2021 (audited)

-

-

Depreciation charge for the year

(1,548)

(1,548)

 

──────

──────

As at February 28, 2022 (audited)

(1,548)

(1,548)

   

Depreciation charge for the period

(23,708)

(23,708)

 

──────

──────

As at November 30, 2022 (unaudited)

(25,256)

(25,256)

 

══════

══════

Carrying amount

  

As at November 30, 2022 (unaudited)

89,134

89,134

As at February 28, 2022 (audited)

54,170

54,170

 

══════

══════

 

9 Share premium

 

Authorised

 

The Company is authorised to issue an unlimited number of nil par value shares of a single class.

 
                                                                                             
    
 

Shares

Share capital

Share premium

Issued ordinary shares of US$0.00 each

 

US$

US$

    

At February 28, 2021 (audited)

75,040,282

-

9,443,676

 

═══════

═══════

═══════

    

Shares issued for cash

158,499,941

-

12,098,924

Shares issued to settle loans

48,618,529

-

2,159,722

Shares issued in lieu of Directors fees

3,037,362

-

145,794

Shares issued to Zenith Minerals Limited *

32,217,765

 

-

Share issue costs capitalised

-

-

(413,731)

 

───────

───────

───────

At February 28, 2022 (audited)

317,413,879

-

23,434,385

 

═══════

═══════

═══════

    

Shares issued for cash (note 11)

73,195,560

-

7,581,351

Share issue costs capitalised

-

-

(547,916)

 

───────

───────

───────

At November 30, 2022 (unaudited)

390,609,439

-

30,467,820

 

═══════

═══════

═══════

    

* In line with the agreement entered into with Zenith Minerals Limited ("Zenith"), shares were issued to Zenith to maintain their shareholding at 15%. Following the listing of the Company's shares on AIM in July 2021, the anti-dilution protection held by Zenith no longer applies to any new issues of shares.

     
 

10 Equity settled share based payments

 

The cost of equity settled transactions with certain Directors of the Company and other participants ("Participants") is measured by reference to the fair value at the date on which they are granted. The fair value is determined based on the Black-Scholes option pricing model.

 

During the nine-month period ended November 30, 2022, outstanding fees due to directors totaling US$ Nil were settled by the issue of shares (28 February 2022: US$Nil)

 

Options and warrants

 

The total number of share options and warrants in issue as at the period end is set out below.

 
                                                                                                                                                                                                    
Recipient 

Grant

 

Date

 
 

Term

 

in years

 
 

Exercise

 

Price

 

Number at March 1, 2022 (audited)

Number Issued

Number Lapsed/ cancelled/expired

Number Exercised

Number at November 30, 2022 (unaudited)

Fair value

 
Options        

US$

 
Directors and Participants

April 2018

5

US$ 0.15668

1,606,304

-

-

-

1,606,304

24,028

 
Directors and Participants

June 2021

5

US$ 0.048

18,000,000

-

-

-

18,000,000

1,110,556

 
Directors and Participants

September 2021

5

£0.09

4,000,000

-

-

-

4,000,000

314,962

 
Directors and Participants

April 2022

5

£0.18

-

9,200,000

-

-

9,200,000

1,122,876

 
           
Warrants          
Supplier warrants

July 2021

5

£0.0550

1,818,182

-

-

-

1,818,182

124,482

 
Supplier warrants

July 2021

3

£0.0825

2,254,545

-

-

-

2,254,545

8,275

 
Shareholder warrants

December 2021

2

£0.0885

1,185,687

-

-

-

1,185,687

44,858

 
Supplier warrants

April 2022

2

£0.1350

-

3,244,331

-

-

3,244,331

284,918

 
           
    

───────

───────

───────

───────

───────

───────

 
    

28,864,718

12,444,331

-

-

41,309,049

3,034,955

 
    

═══════

═══════

═══════

═══════

═══════

═══════

 
                    
 

10 Equity settled share based payments (continued)

 

The amount expensed in the income statement has been calculated by reference to the fair value at the grant date of the equity instrument and the estimated number of equity instruments to vest after the vesting period.

 
               
  

Nine-month period ended November 30, 2022

 

(unaudited)

 

US$

 
 

Nine-month period ended November 30, 2021

 

(unaudited)

 

US$

 
 

Three-month period ended November 30, 2022

 

(unaudited)

 

US$

 
 

Three-month period ended November 30, 2021

 

(unaudited)

 

US$

 

Share based payments charge

1,285,743

259,816

91,539

-

 

═══════

═══════

═══════

═══════

 

The inputs used in the measurement of the fair values at grant date of the equity-settled share-based payment plans issued during the period are as follows:

 

April 2022 options

 
            
 

Award date and exercise price

Fair value at grant date

£0.09308

Exercise price

£0.180

Weight average expected volatility

81.90%

Weighted average expected life (years)

5

Risk-free interest rate (based on comparable companies)

1.52%

 

Terms of the issued options are as follows:

 

- 9,200,000 options have been granted and are subject to the three independent vesting conditions for 1/3 of the entitlement, relating to the successful fund raising in respect of the Group's operational budget, commencement of a drilling program in respect of the San Domingo project and resolution of certain Wickieup project title claims. All un-exercised options expire after a period of 5 years from grant date. It is assumed that options are exercised within 5 years from date of grant. The applied volatility is based on historical volatility.

 

April 2022 supplier warrants

 
            
 

Award date and exercise price

Fair value at grant date

£0.06697

Exercise price

£0.135

Weight average expected volatility

81.90%

Weighted average expected life (years)

2

Risk-free interest rate (based on comparable companies)

0.80%

 

Terms of the issued warrants are as follows:

 

- As part of the fundraise completed during April 2022, certain service providers of the Company received warrants for services rendered. As a result, 3,244,331 warrants have been issued. All un-exercised warrants expire after a period of 2 years from grant date. It is assumed that warrants are exercised within 2 years from date of grant. The applied volatility is based on historical volatility.

 

11 Warrants

 

The cost of equity warrants granted during the period are measured by reference to the fair value at the date on which they are granted. The fair value is determined based on the Black-Scholes option pricing model.

 

During the nine-month period ended November 30, 2022, the Company awarded warrants to investors who participated in the fundraise completed during April 2022.

 

The total number of warrants in issue as at the period end is set out below.

 
                                                            
Recipient 

Grant

 

Date

 
 

Term

 

in years

 
 

Exercise

 

Price

 

Warrants at March 1, 2022 (audited)

Number of Warrants Issued

Number of Warrants Lapsed/ cancelled/expired

Number of Warrants Exercised

Number of Warrants at November 30, 2022 (unaudited)

Fair value

Warrants        

US$

Shareholder warrants

April 2022

2

£0.2100

-

73,195,560

-

-

73,195,560

1,011,485

    

───────

───────

───────

───────

───────

───────

    

-

73,195,560

-

-

73,195,560

1,011,485

    

═══════

═══════

═══════

═══════

═══════

═══════

 

The fair value applied to the shareholder warrants has been classified as a financial liability. At period end, the warrant liability has been re-measured to fair value, with a corresponding entry to profit and loss of US$ 3,711,264 (period ended November 30, 2021: Nil) within Warrant Fair Value Re-Measurement.

 

Reconciliation of warrant liability fair value:

 
                
 

Fair value

 

US$

Balance at March 1, 2022

-

Warrants issued during the period

4,722,749

Fair value re-measurement

(3,711,264)

 

───────

Balance at November 30, 2022

1,011,485

 

═══════

 

11 Warrants (continued)

 

April 2022 shareholder warrants

 
            

Grant date fair value

Award date and exercise price

Fair value at grant date

£0.0492

Exercise price

£0.21

Weight average expected volatility

81.90%

Weighted average expected life (years)

2

Risk-free interest rate (based on comparable companies)

0.80%

 
            

November 30, 2022 fair value

Award date and exercise price

Fair value

£0.0118

Exercise price

£0.21

Weighted average expected volatility

80.5%

Weighted average expected life remaining (years)

1.39

Risk-free interest rate (based on comparable companies)

4.38%

 

As part of the fundraise completed during April 2022, all participating shareholders received a warrant on 1:1 basis for shares acquired. As a result, 73,195,560 warrants have been issued. All un-exercised warrants expire after a period of 2 years from grant date. It is assumed that warrants are exercised within 2 years from date of grant. The applied volatility is based on historical volatility.

 

12 Basic and diluted loss per share

 

The calculation of basic profit per share of the Company is based on the loss for the period of US$ 3,074,862 (nine-month period to November 30, 2021: loss of US$ 2,052,489) and the weighted average number of shares of 379,122,544 (at November 30, 2021: 147,618,936) in issue during the period.

 

Diluted loss per share is calculated by adjusting the weighted average number of ordinary shares outstanding to assume conversion of all dilutive potential ordinary shares such as warrants and options. An adjustment for the dilutive effect of share options and warrants in the current period has not been reflected in the calculation of the diluted loss per share, as the effect would have been anti-dilutive, due the Company recognising a loss for the period.

 

13 Related party transactions and balances

 

Edgewater Associates Limited ("Edgewater")

 

During the nine-month period ended November 30, 2022, Directors' and Officers' insurance was obtained on an arms-length basis through Edgewater, which is a 100% subsidiary of Manx Financial Group ("MFG"). James Mellon and Denham Eke are Directors of both the Company and MFG.

 

During the period, the premium payable on the policy was US$ 49,318 (year ended February 28, 2022: US$ 44,303), of which US$ 32,122 was prepaid as at the period end (February 28, 2022: US$ 11,076).

 

14 Commitments and contingent liabilities

 

The Group has certain obligations to expend minimum amounts on exploration works on mining tenements in order to retain an interest in them, equating to approximately US$ 415,454 during the next 12 months. This includes annual fees in respect of licence renewals. These obligations may be varied from time to time, subject to approval and are expected to be filled in the normal course of exploration and development activities of the Company.

 

15 Events after the reporting date

 

On 21 December 2022, the Company awarded 500,000 ordinary share options each to Euan Jenkins and Alex Borrelli, independent non-executive directors of the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

 

SOURCE: Bradda Head Lithium Limited

 

View source version on accesswire.com:
https://www.accesswire.com/737037/Bradda-Head-Lithium-Ltd-Announces-Unaudited-Interim-Financial-Statements

News Provided by ACCESSWIRE via QuoteMedia

BHLI:CA
The Conversation (0)
Bradda Head Lithium Ltd Announces Delisting from the US OTCQB

Bradda Head Lithium Ltd Announces Delisting from the US OTCQB

 

Bradda Head Lithium Ltd ("Bradda Head", "BHL" or the "Company") (AIM:BHL)(TSX-V:BHLI) the North America-focused lithium development group, announces that the Company has delisted its shares from trading on the US OTCQB Market, with effect from 1 January 2024, due to share trading liquidity expectations not having been met and cost saving in this current market environment

 
 
 
 
 
 
 

The Company's shares continue to trade on the London AIM Market and on the Canadian TSX Venture Exchange.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Bradda Head Lithium Ltd Announces Results of Annual General Meeting

Bradda Head Lithium Ltd Announces Results of Annual General Meeting

 

Bradda Head Lithium Ltd (AIM:BHL, TSX-V:BHLI, OTCQB:BHLIF), the North America-focused lithium development group, announces that at the AGM held yesterday, all resolutions were passed

 

The Company is also pleased to provide an update on its operations, which is available on the Company's website at the link below:

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Bradda Head Lithium Ltd Announces Holding in Company

Bradda Head Lithium Ltd Announces Holding in Company

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)

 
                                                               

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

 

Class/type of
shares

 

ISIN code (if possible)

 

Number of voting rights ix

% of voting rights

 

Direct

 

(DTR5.1)

 
 

Indirect

 

(DTR5.2.1)

 
 

Direct

 

(DTR5.1)

 
 

Indirect

 

(DTR5.2.1)

 
VGG154091083

39,739,569

 

10.17%

 
     

SUBTOTAL 8. A

39,739,569

10.17%

 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expiration
date

Exercise/
Conversion Period

 

Number of voting rights that may be acquired if the instrument is

 

exercised/converted.

 

% of voting rights

     
  

SUBTOTAL 8. B 1

  
 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expiration
date x

Exercise/
Conversion Period

 

Physical or cash

 

Settlement

 

Number of voting rights

% of voting rights

      
   

SUBTOTAL 8.B.2

  
 
          
 
                                       
 

9. Information in relation to the person subject to the notification obligation (please mark the

 

applicable box with an "X")

 

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

 

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary)

X

Name

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Electrification and Decarbonization AIE LP

6.03%

 

6.03%

Li Equities Investments LP

4.15%

 

4.15%

Waratah Advisors GP I Limited

0%

N/A

0%

Waratah Capital Advisors Ltd.

0%

N/A

0%

2401261 Ontario Inc.

0%

N/A

0%

 

10. In case of proxy voting, please identify:

Name of the proxy holder

N/A

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

 

11. Additional information

 

Waratah Advisors GP I Limited is the general partner of Electrification and Decarbonization AIE LP and Li Equities Investments LP and has delegated investment management to Waratah Capital Advisors Ltd. ("Waratah"), which is a wholly owned subsidiary of 2401261 Ontario Inc.

 

Holdings in items 7 and 8 of this document are consolidated for both Electrification and Decarbonization AIE LP and Li Equities Investments LP. Please refer to item 9 for a breakdown of holdings by entity.

 

As of November 20, 2023, Electrification and Decarbonization AIE LP and Li Equities Investments LP own 23,535,515 and 16,204,054 shares, respectively, representing a total percentage ownership of 10.17% based on 390,609,400 issued and outstanding shares.

 

This notification is being made pursuant to Regulation 25.3 of the issuer's articles of association and pursuant to DTR5.

 
     
 
    

Place of completion

Toronto, Canada

Date of completion

21/11/2023

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

 

SOURCE: Bradda Head Lithium Limited

 

View source version on accesswire.com:
https://www.accesswire.com/808429/bradda-head-lithium-ltd-announces-holdings-in-company

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Bradda Head Lithium Ltd - Replacement: San Domingo Update

Bradda Head Lithium Ltd - Replacement: San Domingo Update

 

THIS ANNOUNCEMENT REPLACES THE ANNOUNCEMENT " PHASE 2 DRILLING IDENTIFIES NEW LITHIUM-BEARING PEGMATITE ZONES AT SAN DOMINGO" OF 13 NOVEMBER 2023.

 

· In figure 3: Bolt cross-section and drill hole SD-DH23-057, looking northwest - one of the captions in the image read 5.27m at 5.27%, but should read 5.27m at 0.51%.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Bradda Head Lithium Ltd Announces Positive San Domingo Metallurgical Results

Bradda Head Lithium Ltd Announces Positive San Domingo Metallurgical Results

 

Positive preliminary metallurgical results on samples from Jumbo Spodumene Pegmatite target at San Domingo Pegmatite District, Arizona

 

Bradda Head Lithium Ltd (AIM:BHL)(TSX-V:BHLI)(OTCQB:BHLIF), the North America-focused lithium development group, is pleased to announce positive metallurgical heavy liquid separation ("HLS") results from test work undertaken by the SGS Metallurgical Process Facility in Lakefield, Canada ("SGS Canada") on quartered drill core samples taken from its Jumbo Exploration Target at San Domingo District, Arizona, USA

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Brunswick Exploration Has Now Identified Four Major New Dykes in 2025 at Mirage

Brunswick Exploration Has Now Identified Four Major New Dykes in 2025 at Mirage

 

Brunswick Exploration Inc. (TSX-V: BRW, OTCQB: BRWXF; " BRW " or the " Company ") is pleased to report the final set of results obtained as part of the 2025 Winter drill campaign conducted on its Mirage Project. The Mirage Project is located in the Eeyou Istchee–James Bay region of Quebec, approximately 40 kilometers south of the Trans-Taiga Road. This press release primarily focuses on the drilling work carried out in the eastern extension of the MR-6 dyke and the "Stacked Dyke" zone.

 

  Highlights include:  

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
SAGA Metals Confirms Significant Oxide Layering in the Northwest of the 100% owned Radar Titanium Project in Labrador, Canada

SAGA Metals Confirms Significant Oxide Layering in the Northwest of the 100% owned Radar Titanium Project in Labrador, Canada

 

Saga Metals Corp. ("SAGA" or the "Company") (TSXV: SAGA) (OTCQB: SAGMF) (FSE: 20H) a North American exploration company focused on critical mineral discovery, is pleased to announce SAGA's geophysics team has confirmed significant oxide mineralization in the northwest section of the 100% owned Radar Titanium Property (the "Property) over the site previously drilled back in 1996.

 

  Northwest Zone, Radar Property  

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
Lithium Universe Ltd  Interview with Executive Chairman

Lithium Universe Ltd Interview with Executive Chairman

Melbourne, Australia (ABN Newswire) - Lithium Universe Limited (ASX:LU7) (FRA:KU00) (OTCMKTS:LUVSF) is pleased to announce an interview with Executive Chairman, Iggy Tan at the recent Lithium Supply & Battery Raw Materials Conference in Las Vegas. The interview was conducted by The Rock Stock Channel.

Interview Highlights

- Discussions with potential spodumene feedstock offtakers ongoing

- Further talks with potential OEMs on battery grade lithium carbonate offtake

- All work completed on Becancour Lithium Project - waiting for lithium market recovery

- Acquisition of global rights photovoltaic (PV) solar panel recycling technology

- "Microwave Joule Heating Technology" (MJHT) from Macquarie University

- Utilizes microwave technology to selectively heat and delaminate PV cells

- Today only 15% of waste solar cells are recycled, rest end up in land fill

- Difficult to recycle, high temperature furnace, toxic chemicals, low recovery

- To investigate further recovery of silver, silicon, gallium and indium

To Watch the Interview, please visit:
https://www.abnnewswire.net/lnk/S0S4T95N

 

About Lithium Universe Ltd:  

Lithium Universe Ltd (ASX:LU7) (FRA:KU00) (OTCMKTS:LUVSF), headed by industry trail blazer, Iggy Tan, and the Lithium Universe team has a proven track record of fast-tracking lithium projects, demonstrated by the successful development of the Mt Cattlin spodumene project for Galaxy Resources Limited.

Instead of exploring for the sake of exploration, Lithium Universe's mission is to quickly obtain a resource and construct a spodumene-producing mine in Quebec, Canada. Unlike many other Lithium exploration companies, Lithium Universe possesses the essential expertise and skills to develop and construct profitable projects.

 

 

Source:
Lithium Universe Ltd

News Provided by ABN Newswire via QuoteMedia

Keep reading...Show less

Latest Press Releases

Related News

×